Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06385899
Status:
COMPLETED
Last Update Posted:
2024-04-26
First Post:
2024-04-18
Brief Title:
Effect of Intensive Monitoring of Patients With Poorly Controlled Type 2 Diabetes With Different Glycemic Background
Sponsor:
Goztepe Prof Dr Suleyman Yalcın City Hospital
Organization:
Goztepe Prof Dr Suleyman Yalcın City Hospital
Study Overview
Official Title:
The Effect of Close and Intensive Therapeutic Monitoring of Patients With Poorly Controlled Type 2 Diabetes With Different Glycemic Background
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In Turkey only 55 of patients with type 2 diabetes have been diagnosed and 91 of these patients have been receiving treatment The rate of patients reaching the treatment target is 50 The pandemic has also affected diabetic patients It is aimed to determine the characteristics of patients with type 2 diabetes HbA1c 10 with poor metabolic control and to evaluate the extent to which metabolic control can be achieved in 12 months
Detailed Description:
Patients who applied to Istanbul Medeniyet University Goztepe Prof Dr Suleyman Yalcin City Hospital Diabetes Polyclinics and have an HbA1c levels of 10 in their examinations will be admitted to the study Detailed history including medication usage and previous blood tests will be questioned The patients will be asked to complete questionnaires about their eating patterns mindful eating questionnaire their physical activities General practice physical activity questionnaire and whether the participants have depression Beck depression questionnaire Anthropometric measurements will be taken and biochemical data will be recorded Patients will be grouped according to their previous HbA1c values as a newly diagnosed b those whose diabetes was previously controlled c those whose diabetes was previously not at the target range but now worsened and d those whose diabetes was poorly controlled from the beginning Diabetes follow-up will be continued by their respective physicians The patients will be called again three months after their enrollment to record the most recent biochemical data Patient characteristics age gender educational status depression status eating awareness exercise characteristics will be evaluated in accordance with the predetermined HbA1c groups Again according to the patient groups the difference in HbA1c after three months the frequency of reaching the target and possible factors associated with the findings will be evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None